GINA LAGINYA: Open Payments
NPI 1073179727 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 11 payments from 6 companies in 2025. Trend: 2023 $560 · 2024 $617 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| PFIZER INC. | 2 | $42 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Amgen Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $15 |
Products named: SAPHNELO, COSENTYX, XELJANZ, BENLYSTA, ENBREL, SKYRIZI.
Industry payments across PA — which companies pay providers there.
